Natural Solutions Radio header image


Socioeconomic Factors Hinder Colorectal Cancer Care

Thu Jul 25, 2002

NEW YORK (Reuters Health) - Patients' age, income and type of health insurance appear to play a role in whether they get recommended treatments after a diagnosis of colon or rectal cancer, new study findings suggest.

Currently, experts recommend that people with more advanced cancer (cancer that has spread to surrounding tissue or lymph nodes) get surgery followed by chemotherapy and/or radiotherapy--often referred to as adjuvant care.


UN Steps Up Campaign Against Skin Cancer

Tue Jul 23, 2002

By Richard Waddington

GENEVA (Reuters) - The World Health Organization stepped up a campaign against skin cancer on Tuesday with guidelines to tell people when it is safe to sunbathe.

An internationally agreed ultraviolet index (UVI), showing the intensity of potentially cancer-causing rays, has been in use for years, but the interpretation given to its readings has often differed from country to country.


Strong Identical Twin Breast Cancer Link Identified

Wed Jul 24, 2002

LONDON (Reuters) - Women who have an identical twin with breast cancer have four times the normal chance of developing the disease themselves, American scientists said on Tuesday.

The risk is higher than researchers had previously thought and highlights the role of genetics in the development of the disease, which kills more than 370,000 women worldwide each year.


Cancer Patients Get Inadequate Care for Pain: Panel

Wed Jul 17, 2002

By Joyce Frieden

BETHESDA (Reuters Health) - Pain, fatigue and depression are undertreated in cancer patients even though many good therapies are available, according to a draft statement released Wednesday at a state-of-the-science conference sponsored by the National Institutes of Health .

"Fear of cancer and its consequences must be ameliorated," said Dr. Donald L. Patrick, chair of the panel that drafted the statement. "Cancer pain, depression, and fatigue are undertreated and this is unacceptable.


Urine Test May Catch Bladder Cancer Early

Wed Jul 17, 2002

NEW YORK (Reuters Health) - A urine test for a cancer-linked protein may be better at catching bladder cancer than standard urine testing, UK researchers report.

Although it is too early to say what role the test might have in diagnosing bladder cancer, the study authors say their findings show it is "highly predictive" of the disease.


Protein Bit Pushes Cancer Cells to Suicide

Tue Jul 16, 2002

By Merritt McKinney

NEW YORK (Reuters Health) - German scientists have created a snippet of protein that may help keep cancer cells from becoming resistant to tumor-destroying treatment.

Many cancer drugs work by encouraging tumor cells to commit suicide, a process called apoptosis. Eventually, however, many cancer cells develop a resistance to therapy and ignore the commands to destroy themselves.


Experimental Drug Destroys Liver Cancer

Mon Jul 15, 2002

By Adam Marcus
HealthScoutNews Reporter

MONDAY, July 15 (HealthScoutNews) -- An experimental drug with a taste for energy-thirsty cells appears to kill off liver tumors in rabbits.

Johns Hopkins University scientists found the chemical, known as 3-bromopyruvate, destroys liver cancer and also shrinks tumors that have spread from that organ into the lungs. The substance, which is related to a molecule that occurs naturally in the breakdown of sugar, starves cancerous cells of energy, but appears to leave healthy tissue alone.


Studying Lung Cancer Genes May Help

Sun Jul 14, 2002

By RANDOLPH E. SCHMID, Associated Press Writer

WASHINGTON (AP) - Studying the genes active in early stage lung cancers may help identify which patients are at greatest risk of dying, allowing their doctors to prescribe more aggressive treatment, researchers report.

A team led by Dr. David G. Beer at the University of Michigan found that by studying which of about 50 genes in an early stage tumor are more or less active, it could predict which patients are more likely to relapse within five years.


Screen May Detect High-Risk Lung Cancer

Mon Jul 15, 2002

By Merritt McKinney

NEW YORK (Reuters Health) - Michigan scientists have developed a method of identifying which patients with early-stage lung cancer might benefit most from aggressive treatment.

Though the screening, which looks for genetic markers of aggressive cancer in tumor cells, is not yet ready for widespread use, the analysis eventually may help patients with high-risk cancers live longer, according to researcher Dr. David G. Beer.


Many Cancer Patients Use Complementary Therapies

Mon Jul 15,10:43 AM ET

By Richard Woodman

LONDON (Reuters Health) - More than half of all cancer patients are using complementary or alternative therapies to cope with the difficult side effects of hospital-based treatment, according to a report released on Sunday.

The market consultancy, Datamonitor, said as many as 60% of cancer patients in certain European countries, and 80% in the United States, use special diets, vitamin supplements, herbal remedies or acupuncture.